Validation of Progesterone [Bioanalytics]

posted by Compliance – India, 2013-09-10 12:13 (4280 d 20:44 ago) – Posting: # 11467
Views: 4,314

Dear All,

We are working on Progesterone and I have query related to the approach applied by the CRO while validating the method.

As per my understanding and methods from the various CRO, all have done the validation with stripped and un-stripped plasma for the endogenous molecule. However the CRO with whom we are dealing has validated the method by using female plasma and use only those plasma for the bulk spiking which has shown less or nil endogenous level of progesterone and done the validation as per routine practices/ process applied to routine molecule.

Is this approach is acceptable? however during study we are going to collect 2-3 pre dose sample for the base line correction.

The approach applied by the CRO is new for me and seeking your expert comment on this. Logically I am agree with their approach however only worried about how the regulatory take this.

Regards,

Compliance

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,682 registered users;
63 visitors (0 registered, 63 guests [including 43 identified bots]).
Forum time: 08:57 CEST (Europe/Vienna)

Nerds don’t just happen to dress informally.
They do it too consistently.
Consciously or not, they dress informally
as a prophylactic measure against stupidity.    Paul Graham

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5